Analysis of global channel costs for the pharmaceutical industry
Thesis (M. Eng. in Logistics)--Massachusetts Institute of Technology, Engineering Systems Division, 2009.
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | eng |
| Published: |
Massachusetts Institute of Technology
2010
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/1721.1/53543 |
| _version_ | 1826193154483683328 |
|---|---|
| author | Rimling, Eric C. (Eric Christopher) Seoh, Wontae Thomas |
| author2 | Mahender Singh. |
| author_facet | Mahender Singh. Rimling, Eric C. (Eric Christopher) Seoh, Wontae Thomas |
| author_sort | Rimling, Eric C. (Eric Christopher) |
| collection | MIT |
| description | Thesis (M. Eng. in Logistics)--Massachusetts Institute of Technology, Engineering Systems Division, 2009. |
| first_indexed | 2024-09-23T09:34:34Z |
| format | Thesis |
| id | mit-1721.1/53543 |
| institution | Massachusetts Institute of Technology |
| language | eng |
| last_indexed | 2024-09-23T09:34:34Z |
| publishDate | 2010 |
| publisher | Massachusetts Institute of Technology |
| record_format | dspace |
| spelling | mit-1721.1/535432019-04-12T10:01:43Z Analysis of global channel costs for the pharmaceutical industry Rimling, Eric C. (Eric Christopher) Seoh, Wontae Thomas Mahender Singh. Massachusetts Institute of Technology. Engineering Systems Division. Massachusetts Institute of Technology. Engineering Systems Division. Engineering Systems Division. Thesis (M. Eng. in Logistics)--Massachusetts Institute of Technology, Engineering Systems Division, 2009. Includes bibliographical references (leaves 77-78). The pharmaceutical industry creates products which often have more than one supply chain channel, defined as a route through the supply chain network from sourcing to the end market. Each channel's specific cost characteristics are important to the pharmaceutical industry's ability to maintain positive profit margins while meeting high customer service requirements. Determining the optimal supply chain channel involves the analysis of fuel costs, logistics, taxes, wage differences, and many more. Additionally, variables such as time and risk significantly impact the total cost of a supply chain channel, but are extremely difficult to quantify. In this research, we identify the relevant channel costs and variables for the supply chain of a large pharmaceutical corporation. After identification, our study categorizes each cost based on level of measurability and causes of variability to develop a framework identifying the most relevant costs by four product types. We then analyze market forces that affect costs over a product's lifecycle. Finally, we develop an operational model for using the framework to compare costs across multiple supply chain channels and time horizons. by Eric C. Rimling and Wontae Thomas Seoh. M.Eng.in Logistics 2010-04-07T13:39:01Z 2010-04-07T13:39:01Z 2009 2009 Thesis http://hdl.handle.net/1721.1/53543 497151365 eng M.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission. http://dspace.mit.edu/handle/1721.1/7582 90 leaves application/pdf Massachusetts Institute of Technology |
| spellingShingle | Engineering Systems Division. Rimling, Eric C. (Eric Christopher) Seoh, Wontae Thomas Analysis of global channel costs for the pharmaceutical industry |
| title | Analysis of global channel costs for the pharmaceutical industry |
| title_full | Analysis of global channel costs for the pharmaceutical industry |
| title_fullStr | Analysis of global channel costs for the pharmaceutical industry |
| title_full_unstemmed | Analysis of global channel costs for the pharmaceutical industry |
| title_short | Analysis of global channel costs for the pharmaceutical industry |
| title_sort | analysis of global channel costs for the pharmaceutical industry |
| topic | Engineering Systems Division. |
| url | http://hdl.handle.net/1721.1/53543 |
| work_keys_str_mv | AT rimlingericcericchristopher analysisofglobalchannelcostsforthepharmaceuticalindustry AT seohwontaethomas analysisofglobalchannelcostsforthepharmaceuticalindustry |